Lawrence, N <br/><br/>
Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP).  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  12 2016 
 - 2302-2303 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdw313  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Australia--epidemiology<br/>Bleomycin--administration & dosage<br/>Cisplatin--administration & dosage<br/>Clinical Trials, Phase II as Topic<br/>Etoposide--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Multicenter Studies as Topic<br/>Neoplasms, Germ Cell and Embryonal--diagnosis<br/>New Zealand--epidemiology<br/>Prostatic Neoplasms--diagnosis<br/>Time Factors<br/>Treatment Outcome<br/>Urogenital Neoplasms--diagnosis